The net proceeds of about $6.5 million will be used for working capital and general corporate purposes. The sale is expected to result in a pre-tax gain of approximately $5.7 million in the fourth fiscal quarter ending June 30.
This sale aligns with SunLink’s strategy to position itself for a potential extraordinary transaction, such as a merger or consolidation, improve its operations, and consider selling non-performing assets. The company aims to find a strategic transaction that offers shareholders a chance for future value appreciation with acceptable risk.
See Also: Dave Portnoy Blasts E*Trade Amid Roaring Kitty Ban Considerations
How To Buy SSY Stock
By now you're likely curious about how to participate in the market for SunLink Health Systems – be it to purchase shares, or even attempt to bet against the company.
In the the case of SunLink Health Systems, which is trading at $0.6 as of publishing time, $100 would buy you 166.67 shares of stock.
According to data from Benzinga Pro, SSY has a 52-week high of $1.05 and a 52-week low of $0.53.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
